Serarslan, G. Et Al. 2010. Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease. CLINICAL AND EXPERIMENTAL DERMATOLOGY , vol.35, no.5 , 487-490.

Serarslan, G., YÖNDEN, Z., Sogut, S., SAVAŞ, N., Celik, E., & ARPACI, A., (2010). Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease. CLINICAL AND EXPERIMENTAL DERMATOLOGY , vol.35, no.5, 487-490.

Serarslan, GAMZE Et Al. "Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease," CLINICAL AND EXPERIMENTAL DERMATOLOGY , vol.35, no.5, 487-490, 2010

Serarslan, GAMZE Et Al. "Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease." CLINICAL AND EXPERIMENTAL DERMATOLOGY , vol.35, no.5, pp.487-490, 2010

Serarslan, G. Et Al. (2010) . "Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease." CLINICAL AND EXPERIMENTAL DERMATOLOGY , vol.35, no.5, pp.487-490.

@article{article, author={GAMZE SERARSLAN Et Al. }, title={Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease}, journal={CLINICAL AND EXPERIMENTAL DERMATOLOGY}, year=2010, pages={487-490} }